IL17A and neoplasm: The specific requirement for IL-17 to drive carcinogenesis, distinct from other inflammatory contexts, was highlighted by a Treg depletion study, which shifted the cytokine profile from an IL-17 to an IFN-γ bias, increasing colitis and decreasing tumor growth (67).